KRISTIN DAVIS: Open Payments
NPI 1508182726 · CAMDEN, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$430 in 23 payments from 10 companies in 2025. Trend: 2023 $219 · 2024 $536 · 2025 $430
Food & beverage: $430
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 7 | $108 |
| ABBVIE INC. | 4 | $85 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $66 |
| Lundbeck LLC | 2 | $40 |
| PFIZER INC. | 2 | $35 |
| Novo Nordisk Inc | 1 | $28 |
| AstraZeneca Pharmaceuticals LP | 1 | $24 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
| Amgen Inc. | 1 | $15 |
| Lilly USA, LLC | 1 | $14 |
Products named: Auvelity, CAPLYTA, QULIPTA, REXULTI, NURTEC ODT, Wegovy, AIRSUPRA, UBRELVY.
Industry payments across TN — which companies pay providers there.
